Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept Study on LTX-109 as Treatment for Hidradenitis Suppurativa

NCT04756336 is registered in ClinicalTrials.gov with Pharma Holdings AS as lead sponsor.

NCT NCT04756336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04756336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept Study on LTX-109 as Treatment for Hidradenitis Suppurativa
Lead sponsor
Pharma Holdings AS
Phase
Phase 1/2
Overall status
Completed
Start date
March 5, 2021
Completion date
July 1, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa